Fundz

Arsanis, Inc. reported raising $4 Million in an initial SEC Form D filing, from an offering of $4 Million

PUBLIC · XFORDec 30, 2015

Amount Raised

$4 Million

$4 Million sold, per SEC Form D (first sale Dec 30, 2015)

Round Type

Seed

BostonBiotechnologyHealthcare

Who to call at X4 Pharmaceuticals, and when

A new round usually means X4 Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day X4 Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at X4 Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at X4 Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

X4 Pharmaceuticals

Location

61 NORTH BEACON STREET

Boston, Massachusetts, United States

About

X4 Pharmaceuticals is a fully integrated, commercial-stage biopharmaceutical company focused on driving progress for people living with rare immune disorders. The company listens to those whose challenges have been long overlooked, develops solutions to their most urgent health concerns, and delivers impact through its FDA-approved medication XOLREMDI® (mavorixafor), now commercially available in the U.S. in its first indication. X4 is also evaluating mavorixafor in additional potential indications, including an ongoing global, pivotal Phase 3 clinical trial for chronic neutropenia. Headquartered in Boston, Massachusetts, X4 Pharmaceuticals is committed to advancing innovative treatments that make a difference.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment X4 Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAdam M., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for X4 Pharmaceuticals's next move

See what Strategic adds

X4 Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.